{"count": 19, "results": [{"_id": "31089386", "pmid": 31089386, "pmcid": "PMC6487397", "title": "Evaluation of the Effect of Atenolol Induced Depression in Cardiac Output on Its Own Excretion through Urine Analysis", "journal": "Iran J Pharm Res", "authors": ["Khan S", "Mahmood W"], "date": "2019-01-01T00:00:00Z", "meta_date_publication": "2019 Winter", "meta_volume": "18", "meta_issue": "1", "meta_pages": "523-530", "score": 50104.93, "text_hl": "., 2001 supports our results who concluded that @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ causes an early significant @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@reduction of heart rate and CO@@@. ", "citations": {"NLM": "Khan S, Mahmood W. Evaluation of the Effect of Atenolol Induced Depression in Cardiac Output on Its Own Excretion through Urine Analysis Iran J Pharm Res. 2019 Winter;18(1):523-530. PMID: 31089386", "BibTeX": "@article{31089386, title={Evaluation of the Effect of Atenolol Induced Depression in Cardiac Output on Its Own Excretion through Urine Analysis}, author={Khan S and Mahmood W}, journal={Iran J Pharm Res}, volume={18}, number={1}, pages={523-530}}"}}, {"_id": "973971", "pmid": 973971, "title": "Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.", "journal": "Br J Clin Pharmacol", "authors": ["Lund-Johansen P"], "date": "1976-06-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1976.tb00620.x", "meta_date_publication": "1976 Jun", "meta_volume": "3", "meta_issue": "3", "meta_pages": "445-51", "score": 50083.62, "text_hl": "1 Thirteen @SPECIES_9606 @@@men@@@ with untreated @DISEASE_Essential_Hypertension @DISEASE_MESH:D000075222 @@@essential hypertension@@@ in WHO stage I were studied on an @SPECIES_9606 @@@outpatient@@@ basis to evaluate the haemodynamic long-tern effect of a new beta-adrenoceptor blocker, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. 2 @CHEMICAL_Oxygen @CHEMICAL_MESH:D010100 @@@Oxygen@@@ consumption, heart rate, cardiac @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@output@@@ (Cardiogreen) and intraarterial branchial pressure were recorded at rest in a supine and sitting position and during steady state work at 300, 600 and 900 kpm/min. 3 The subjects were treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (dose 100-200 mg/day) as the sole drug for 1 year and the haemodynamic study was repeated. 4 The blood pressure was reduced approximately 18% both at rest and during exercise, the heart rate approximately 25% and the cardiac @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@output@@@ 16% at rest supine and 27% at rest sitting. ", "citations": {"NLM": "Lund-Johansen P. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension. Br J Clin Pharmacol. 1976 Jun;3(3):445-51. PMID: 973971", "BibTeX": "@article{973971, title={Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.}, author={Lund-Johansen P}, journal={Br J Clin Pharmacol}, volume={3}, number={3}, pages={445-51}}"}}, {"_id": "695651", "pmid": 695651, "title": "[Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].", "journal": "Wien Klin Wochenschr", "authors": ["Zilcher H", "Glogar D", "Uhlir H", "Leisch F", "Niederberger M", "Steinbach K"], "date": "1978-09-01T00:00:00Z", "meta_date_publication": "1978 Sep 1", "meta_volume": "90", "meta_issue": "16", "meta_pages": "611-6", "score": 50072.54, "text_hl": "These results lead to the conclusion that the antihypertensive action of the cardioselective beta-blocker, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ is based on a lowering of the increased peripheral vascular resistance and a @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@reduction in cardiac output@@@; the latter mechanism is predominantly found in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hyperkinesis @DISEASE_MESH:D006948 @@@hyperkinetic@@@ features.", "citations": {"NLM": "Zilcher H, Glogar D, Uhlir H, Leisch F, Niederberger M, Steinbach K. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl]. Wien Klin Wochenschr. 1978 Sep 1;90(16):611-6. PMID: 695651", "BibTeX": "@article{695651, title={[Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].}, author={Zilcher H and Glogar D and Uhlir H and Leisch F and Niederberger M and Steinbach K}, journal={Wien Klin Wochenschr}, volume={90}, number={16}, pages={611-6}}"}}, {"_id": "6871455", "pmid": 6871455, "title": "[Effect of atenolol and propranolol on systemic and regional hemodynamics].", "journal": "Biull Eksp Biol Med", "authors": ["Medvedev OS", "Iuzhakov SD", "Mashkovskiĭ MD", "Val'dman AV", "Ismailov ShI"], "date": "1983-07-01T00:00:00Z", "meta_date_publication": "1983 Jul", "meta_volume": "96", "meta_issue": "7", "meta_pages": "59-61", "score": 50071.953, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ provoked a @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@decrease in cardiac output@@@ and raised the total peripheral resistance without a detectable effect on blood pressure. ", "citations": {"NLM": "Medvedev OS, Iuzhakov SD, Mashkovskiĭ MD, Val'dman AV, Ismailov ShI. [Effect of atenolol and propranolol on systemic and regional hemodynamics]. Biull Eksp Biol Med. 1983 Jul;96(7):59-61. PMID: 6871455", "BibTeX": "@article{6871455, title={[Effect of atenolol and propranolol on systemic and regional hemodynamics].}, author={Medvedev OS and Iuzhakov SD and Mashkovskiĭ MD and Val'dman AV and Ismailov ShI}, journal={Biull Eksp Biol Med}, volume={96}, number={7}, pages={59-61}}"}}, {"_id": "2913765", "pmid": 2913765, "title": "Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers.", "journal": "Am J Med", "authors": ["Thompson PD", "Cullinane EM", "Nugent AM", "Sady MA", "Sady SP"], "date": "1989-01-23T00:00:00Z", "doi": "10.1016/0002-9343(89)90143-5", "meta_date_publication": "1989 Jan 23", "meta_volume": "86", "meta_issue": "1B", "meta_pages": "104-9", "score": 50071.176, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ also increased @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ volume and the arterial venous @CHEMICAL_Oxygen @CHEMICAL_MESH:D010100 @@@oxygen@@@ difference and reduced @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@cardiac output@@@ during cycle exercise. ", "citations": {"NLM": "Thompson PD, Cullinane EM, Nugent AM, Sady MA, Sady SP. Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers. Am J Med. 1989 Jan 23;86(1B):104-9. PMID: 2913765", "BibTeX": "@article{2913765, title={Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers.}, author={Thompson PD and Cullinane EM and Nugent AM and Sady MA and Sady SP}, journal={Am J Med}, volume={86}, number={1B}, pages={104-9}}"}}, {"_id": "7118065", "pmid": 7118065, "title": "Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.", "journal": "Hepatology", "authors": ["Hillon P", "Lebrec D", "Muńoz C", "Jungers M", "Goldfarb G", "Benhamou JP"], "date": "1982-09-01T00:00:00Z", "doi": "10.1002/hep.1840020503", "meta_date_publication": "1982 Sep-Oct", "meta_volume": "2", "meta_issue": "5", "meta_pages": "528-31", "score": 50067.348, "text_hl": "One hour after p.o. administration of 100 mg of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@cardiac output@@@ decreased by 32%, and portal venous pressure by 16%; the decrease in @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@cardiac output@@@ and the decrease in portal venous pressure were significantly correlated. ", "citations": {"NLM": "Hillon P, Lebrec D, Muńoz C, Jungers M, Goldfarb G, Benhamou JP. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis. Hepatology. 1982 Sep-Oct;2(5):528-31. PMID: 7118065", "BibTeX": "@article{7118065, title={Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.}, author={Hillon P and Lebrec D and Muńoz C and Jungers M and Goldfarb G and Benhamou JP}, journal={Hepatology}, volume={2}, number={5}, pages={528-31}}"}}, {"_id": "11530124", "pmid": 11530124, "title": "Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth.", "journal": "Obstet Gynecol", "authors": ["Easterling TR", "Carr DB", "Brateng D", "Diederichs C", "Schmucker B"], "date": "2001-09-01T00:00:00Z", "doi": "10.1016/s0029-7844(01)01477-6", "meta_date_publication": "2001 Sep", "meta_volume": "98", "meta_issue": "3", "meta_pages": "427-33", "score": 50060.78, "text_hl": "METHODS: A retrospective review of @SPECIES_9606 @@@patients@@@ treated in early pregnancy with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ was conducted. ", "citations": {"NLM": "Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol. 2001 Sep;98(3):427-33. PMID: 11530124", "BibTeX": "@article{11530124, title={Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth.}, author={Easterling TR and Carr DB and Brateng D and Diederichs C and Schmucker B}, journal={Obstet Gynecol}, volume={98}, number={3}, pages={427-33}}"}}, {"_id": "3742933", "pmid": 3742933, "title": "The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.", "journal": "Clin Pharmacol Ther", "authors": ["Holtzman JL", "Finley D", "Johnson B", "Berry DA", "Sirgo MA"], "date": "1986-09-01T00:00:00Z", "doi": "10.1038/clpt.1986.174", "meta_date_publication": "1986 Sep", "meta_volume": "40", "meta_issue": "3", "meta_pages": "268-73", "score": 50059.73, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ both significantly @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@reduced cardiac output@@@ (-0.55 vs. -0.31 L/min) and heart rate (-8.0 vs. -6.6 bpm), whereas @CHEMICAL_Labetalol @CHEMICAL_MESH:D007741 @@@labetalol@@@ had no effect on either parameter (-0.08 L/min; + 1.0 bpm). ", "citations": {"NLM": "Holtzman JL, Finley D, Johnson B, Berry DA, Sirgo MA. The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function. Clin Pharmacol Ther. 1986 Sep;40(3):268-73. PMID: 3742933", "BibTeX": "@article{3742933, title={The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.}, author={Holtzman JL and Finley D and Johnson B and Berry DA and Sirgo MA}, journal={Clin Pharmacol Ther}, volume={40}, number={3}, pages={268-73}}"}}, {"_id": "10912975", "pmid": 10912975, "title": "Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.", "journal": "Obstet Gynecol", "authors": ["Easterling TR", "Brateng D", "Schmucker B", "Brown Z", "Millard SP"], "date": "1999-05-01T00:00:00Z", "doi": "10.1016/s0029-7844(98)00522-5", "meta_date_publication": "1999 May", "meta_volume": "93", "meta_issue": "5 Pt 1", "meta_pages": "725-33", "score": 50056.473, "text_hl": "Mothers of the smallest infants who were treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ could be identified by unexpectedly large @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@reductions in cardiac output@@@. ", "citations": {"NLM": "Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol. 1999 May;93(5 Pt 1):725-33. PMID: 10912975", "BibTeX": "@article{10912975, title={Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.}, author={Easterling TR and Brateng D and Schmucker B and Brown Z and Millard SP}, journal={Obstet Gynecol}, volume={93}, number={5 Pt 1}, pages={725-33}}"}}, {"_id": "2801572", "pmid": 2801572, "title": "Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device.", "journal": "Am J Cardiol", "authors": ["Silke B", "Zezulka AV", "Verma SP", "Taylor SH"], "date": "1989-10-17T00:00:00Z", "doi": "10.1016/0002-9149(89)90978-8", "meta_date_publication": "1989 Oct 17", "meta_volume": "64", "meta_issue": "15", "meta_pages": "28H-34H", "score": 50055.477, "text_hl": "When @CHEMICAL_Nicardipine @CHEMICAL_MESH:D009529 @@@nicardipine@@@ was given after the cardioselective beta blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ the reduction in heart rate @<m>DISEASE_Cardiac_Output_Low</m> @DISEASE_MESH:D002303 @@@and cardiac output@@@ after @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ was reversed compared with a group that received @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ followed by placebo. ", "citations": {"NLM": "Silke B, Zezulka AV, Verma SP, Taylor SH. Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device. Am J Cardiol. 1989 Oct 17;64(15):28H-34H. PMID: 2801572", "BibTeX": "@article{2801572, title={Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device.}, author={Silke B and Zezulka AV and Verma SP and Taylor SH}, journal={Am J Cardiol}, volume={64}, number={15}, pages={28H-34H}}"}}]}